142 related articles for article (PubMed ID: 24903541)
1. Somatic mosaicism for the p.His1047Arg mutation in PIK3CA in a girl with mesenteric lipomatosis.
Cohen AS; Townsend KN; Xiang QS; Attariwala R; Borchers C; Senger C; Picker W; Levi J; Yewchuk L; Tan J; Eydoux P; Lum A; Yong SL; McKinnon ML; Lear SA; Everett R; Jones SJ; Yip S; Gibson WT
Am J Med Genet A; 2014 Sep; 164A(9):2360-4. PubMed ID: 24903541
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA activating mutations in facial infiltrating lipomatosis.
Maclellan RA; Luks VL; Vivero MP; Mulliken JB; Zurakowski D; Padwa BL; Warman ML; Greene AK; Kurek KC
Plast Reconstr Surg; 2014 Jan; 133(1):12e-19e. PubMed ID: 24374682
[TBL] [Abstract][Full Text] [Related]
3. PIK3CA mutations in lipomatosis of nerve with or without nerve territory overgrowth.
Blackburn PR; Milosevic D; Marek T; Folpe AL; Howe BM; Spinner RJ; Carter JM
Mod Pathol; 2020 Mar; 33(3):420-430. PubMed ID: 31481664
[TBL] [Abstract][Full Text] [Related]
4. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum.
Keppler-Noreuil KM; Sapp JC; Lindhurst MJ; Parker VE; Blumhorst C; Darling T; Tosi LL; Huson SM; Whitehouse RW; Jakkula E; Grant I; Balasubramanian M; Chandler KE; Fraser JL; Gucev Z; Crow YJ; Brennan LM; Clark R; Sellars EA; Pena LD; Krishnamurty V; Shuen A; Braverman N; Cunningham ML; Sutton VR; Tasic V; Graham JM; Geer J; Henderson A; Semple RK; Biesecker LG
Am J Med Genet A; 2014 Jul; 164A(7):1713-33. PubMed ID: 24782230
[TBL] [Abstract][Full Text] [Related]
5. Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA.
Lindhurst MJ; Parker VE; Payne F; Sapp JC; Rudge S; Harris J; Witkowski AM; Zhang Q; Groeneveld MP; Scott CE; Daly A; Huson SM; Tosi LL; Cunningham ML; Darling TN; Geer J; Gucev Z; Sutton VR; Tziotzios C; Dixon AK; Helliwell T; O'Rahilly S; Savage DB; Wakelam MJ; Barroso I; Biesecker LG; Semple RK
Nat Genet; 2012 Jun; 44(8):928-33. PubMed ID: 22729222
[TBL] [Abstract][Full Text] [Related]
6. Segmental overgrowth syndrome due to an activating PIK3CA mutation identified in affected muscle tissue by exome sequencing.
Rasmussen M; Sunde L; Weigert KP; Bogaard PW; Lildballe DL
Am J Med Genet A; 2014 May; 164A(5):1318-21. PubMed ID: 24665065
[TBL] [Abstract][Full Text] [Related]
7. Somatic mosaicism of the PIK3CA gene identified in a Hungarian girl with macrodactyly and syndactyly.
Tripolszki K; Knox R; Parker V; Semple R; Farkas K; Sulák A; Horváth E; Széll M; Nagy N
Eur J Med Genet; 2016 Apr; 59(4):223-6. PubMed ID: 26851524
[TBL] [Abstract][Full Text] [Related]
8. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation.
Keppler-Noreuil KM; Rios JJ; Parker VE; Semple RK; Lindhurst MJ; Sapp JC; Alomari A; Ezaki M; Dobyns W; Biesecker LG
Am J Med Genet A; 2015 Feb; 167A(2):287-95. PubMed ID: 25557259
[TBL] [Abstract][Full Text] [Related]
9. The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS).
Suzuki Y; Enokido Y; Yamada K; Inaba M; Kuwata K; Hanada N; Morishita T; Mizuno S; Wakamatsu N
Oncotarget; 2017 Jul; 8(28):45470-45483. PubMed ID: 28525374
[TBL] [Abstract][Full Text] [Related]
10. Somatic PIK3CA mutations are present in multiple tissues of facial infiltrating lipomatosis.
Couto JA; Konczyk DJ; Vivero MP; Kozakewich HPW; Upton J; Fu X; Padwa BL; Mulliken JB; Warman ML; Greene AK
Pediatr Res; 2017 Nov; 82(5):850-854. PubMed ID: 28665924
[TBL] [Abstract][Full Text] [Related]
11. Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America.
Garneau AP; Haydock L; Tremblay LE; Isenring P
J Mol Med (Berl); 2021 Mar; 99(3):311-313. PubMed ID: 33392635
[No Abstract] [Full Text] [Related]
12. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.
Luks VL; Kamitaki N; Vivero MP; Uller W; Rab R; Bovée JV; Rialon KL; Guevara CJ; Alomari AI; Greene AK; Fishman SJ; Kozakewich HP; Maclellan RA; Mulliken JB; Rahbar R; Spencer SA; Trenor CC; Upton J; Zurakowski D; Perkins JA; Kirsh A; Bennett JT; Dobyns WB; Kurek KC; Warman ML; McCarroll SA; Murillo R
J Pediatr; 2015 Apr; 166(4):1048-54.e1-5. PubMed ID: 25681199
[TBL] [Abstract][Full Text] [Related]
13. Activating PIK3CA somatic mutation in congenital unilateral isolated muscle overgrowth of the upper extremity.
Castiglioni C; Bertini E; Orellana P; Villarroel C; Las Heras F; Hinzpeter D; Paolinelli P; Bevilacqua JA; Alvarez K
Am J Med Genet A; 2014 Sep; 164A(9):2365-9. PubMed ID: 24975390
[TBL] [Abstract][Full Text] [Related]
14. Congenital infiltrating lipomatosis of the face with lingual mucosal neuromas associated with a PIK3CA mutation.
Briand C; Galmiche-Rolland L; Vabres P; Couloigner V; Audebert S; Misery L; Abasq-Thomas C
Pediatr Dermatol; 2020 Nov; 37(6):1128-1130. PubMed ID: 32770747
[TBL] [Abstract][Full Text] [Related]
15. An investigation of PIK3CA mutations in isolated macrodactyly.
Wu J; Tian W; Tian G; Sumner K; Hutchinson DT; Ji Y
J Hand Surg Eur Vol; 2018 Sep; 43(7):756-760. PubMed ID: 29661094
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and molecular characterization of five patients with PIK3CA-related overgrowth spectrum (PROS).
Gökpınar İli E; Taşdelen E; Durmaz CD; Altıner Ş; Tuncalı T; Martinez-Glez V; Karabulut HG; Vural S; Ceylaner S; Acar MO; Ilgın Ruhi H
Am J Med Genet A; 2022 Jun; 188(6):1792-1800. PubMed ID: 35238469
[TBL] [Abstract][Full Text] [Related]
17. Utility of clinical high-depth next generation sequencing for somatic variant detection in the PIK3CA-related overgrowth spectrum.
Hucthagowder V; Shenoy A; Corliss M; Vigh-Conrad KA; Storer C; Grange DK; Cottrell CE
Clin Genet; 2017 Jan; 91(1):79-85. PubMed ID: 27307077
[TBL] [Abstract][Full Text] [Related]
18. PIK3CA Mutational Analysis in Patients With Macrodactyly.
Becker J; Gross UC; Weber DM; Weibel L; Theiler M; Brandt S; Bode PK
Pediatr Dev Pathol; 2022; 25(6):624-634. PubMed ID: 36314082
[TBL] [Abstract][Full Text] [Related]
19. Fibroadipose hyperplasia versus Proteus syndrome: segmental overgrowth with a mosaic mutation in the PIK3CA gene.
Youssefian L; Vahidnezhad H; Baghdadi T; Ghaznavi A; Li Q; Tabrizi M; Uitto J
J Invest Dermatol; 2015 May; 135(5):1450-1453. PubMed ID: 25602158
[No Abstract] [Full Text] [Related]
20. [PIK3CA-related overgrowth syndrome (PROS)].
Venot Q; Canaud G
Nephrol Ther; 2017 Apr; 13 Suppl 1():S155-S156. PubMed ID: 28577738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
